Loading…
India is shifting focus from generic drug manufacturing to high-value innovation in medicine.
The government has launched the National Policy on Research and Development (2023) and the ₹5,000 crore PRIP scheme.
The Bio-E3 Policy (2024) and modernised clinical trial rules aim to create a self-reliant ecosystem for drug discovery.
The initiative targets indigenous design and manufacturing of precision medicine, particularly for rare genetic disorders.
Precision medicine is an innovative medical approach that tailors disease treatment and prevention strategies to individual patients, considering their unique genetic makeup, environmental factors, and lifestyle. This allows for more accurate prediction of which treatments will be effective for specific groups of people, moving beyond a 'one-size-fits-all' approach.
Simple Analogy: Instead of giving everyone the same standard medicine, precision medicine is like a tailor making a custom suit for each person, ensuring the perfect fit and effectiveness based on their unique biological measurements.
To promote and support fundamental research and innovation across various sectors, including healthcare, fostering a robust R&D ecosystem.
Key: Aims to transition India towards high-value innovation from generic manufacturing.
To provide financial support for research and development activities in the pharmaceutical and medical technology sectors.
Key: Allocated ₹5,000 crore to boost indigenous innovation and self-reliance in these critical areas.
To foster a self-reliant ecosystem for cutting-edge drug discovery and precision medicine in India.
Key: Likely focuses on enabling infrastructure, regulatory support, and funding mechanisms for biotechnology and biomedical research.
The policies and schemes directly support the 'Self-Reliant India' vision by promoting indigenous research, development, and manufacturing in the healthcare sector.
These initiatives are expected to significantly boost the growth, innovation capabilities, and global competitiveness of India's biotechnology and pharmaceutical industries.
The development of precision medicine can lead to more effective and targeted treatments for various diseases, including rare genetic disorders, thereby improving overall public health.
GS-III (Science & Technology – Developments and their applications, Indigenization of technology, Bio-technology); GS-II (Government Policies and Interventions for Development in various sectors).
General Science, Current Affairs (Government schemes, policies).
General Awareness (Government schemes, economic policies related to industry).
General Science, Current Affairs (broader national development initiatives).
Consider the following statements : 1. The India Sanitation Coalition is a platform to promote sustainable sanitation and is funded by the Government of India and the World Health Organization. 2. The National Institute of Urban Affairs is an apex body of the Ministry of Housing and Urban Affairs in Government of India and provides innovative solutions to address the challenges of Urban India. Which of the statements given above is/are correct?
Answer: 2 only
Consider the following statements about Particularly Vulnerable Tribal Groups (PVTGs) in India: 1. PVTGs reside in 18 States and one Union Territory. 2. A stagnant or declining population is one of the criteria for determining PVTG status. 3. There are 95 PVTGS officially notified in the country so far. 4. Irular and Konda Reddi tribes are included in the list of PVTGs. Which of the statements given above are correct?
Answer: 1, 2 and 4
The object of the Butler Committee of 1927 was to
Answer: Improve the relationship between the Government of India and the Indian States.
Medium-High for UPSC (Science & Tech, Government Schemes); Medium for SSC/Banking (Current Affairs).
A medical model that customizes healthcare, with decisions and treatments tailored to each individual patient.
Diseases caused by genetic mutations, affecting a small percentage of the population, often requiring specialized research and treatment.
A system capable of sustaining itself without external dependence, particularly in technology, innovation, and manufacturing.